Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Other Operating Expenses (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Other Operating Expenses for 4 consecutive years, with $115000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 98.49% year-over-year to $115000.0, compared with a TTM value of $27.9 million through Sep 2025, up 60.6%, and an annual FY2024 reading of $21.0 million, changed N/A over the prior year.
  • Other Operating Expenses was $115000.0 for Q3 2025 at Atara Biotherapeutics, down from $554000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $50.2 million in Q2 2022 and bottomed at $115000.0 in Q3 2025.
  • Average Other Operating Expenses over 4 years is $9.6 million, with a median of $3.9 million recorded in 2023.
  • Peak annual rise in Other Operating Expenses hit 929.67% in 2025, while the deepest fall reached 98.49% in 2025.
  • Year by year, Other Operating Expenses stood at $50.2 million in 2022, then crashed by 93.71% to $3.2 million in 2023, then skyrocketed by 115.03% to $6.8 million in 2024, then crashed by 98.31% to $115000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for ATRA at $115000.0 in Q3 2025, $554000.0 in Q2 2025, and $20.4 million in Q1 2025.